Table 3. Multivariable analysis results for disease free survival (phase I; n = 236).
Variables | p-value | HR | 95% CI (lower) | 95% CI (upper) |
LOX rs10519694 (CT+TT vs CC) | 0.113 | 0.767 | 0.552 | 1.065 |
HIF2A rs11125070 (AT+TT vs AA) | 0.004 | 0.619 | 0.446 | 0.859 |
Age | <0.001 | 1.034 | 1.019 | 1.048 |
Grade (poorly differentiated/undifferentiated vs well/moderately differentiated) | 0.099 | 1.437 | 0.934 | 2.213 |
Stage | <0.001 | |||
Stage (II vs I) | 0.112 | 1.553 | 0.903 | 2.673 |
Stage (III vs I) | <0.001 | 2.93 | 1.684 | 5.095 |
Stage (IV vs I) | <0.001 | 133.705 | 55.984 | 319.324 |
MSI status (MSI-H vs MSS/MSI-L) | 0.013 | 0.4 | 0.194 | 0.825 |
CI: confidence interval, HR: hazard ratio, MSI-H: microsatellite instability-high, MSI-L: microsatellite instability-low, MSS: microsatellite stable, n: number of patients. Significant associations (p<0.05) are shown in bold.